Pfizer stock was trading up at $44.53 as of 11:21 AM EDT.
Angela Lukin, a Pfizer executive, told Reuters that the company plans to raise the price of its COVID vaccine by about four times, to between $100 and $130 per dose. Reuters got this information from Pfizer. According to her LinkedIn profile, Lukin is the Global Primary Care & U.S. President at Pfizer. She stated that she anticipates that consumers with private insurance or government-funded insurance will be able to get the COVID shot for free.
The government currently offers COVID immunization without charge to everyone. The US government buys the vaccine from Pfizer and BioNTech (NASDAQ:BNTX) for about $30 per dose. The vaccine is sold under the name Comirnaty. The article also said that Wall Street expected prices to go up because fewer people were getting COVID vaccines. Even the U.S. distribution of upgraded COVID vaccines targeting the Omicron subvariant was said to be off to a rocky start earlier this week.
The Reuters article says that when the public health emergency in the U.S. ends in 2023, the market will likely move toward private insurance. Still, the World Health Organization (WHO) has said again that COVID-19 is still a serious health emergency on a global scale. Still, the World Health Organization (WHO) has said again that COVID-19 is still a serious health emergency on a global scale.
Pfizer stock outstanding for dividend income
Pfizer (NYSE:PFE) is currently paying out a dividend of $0.4 per share. This gives it a yield of 3.63%, which is higher than the yield of the S&P 500 (2.76%) and the yield of the Large Cap Pharmaceuticals industry (2.76%). The company’s annualized dividend growth during the previous year was 2.56%. View the dividend history for Pfizer (NYSE:PFE) here.
Phillips 66 (PSX), which now pays a dividend of $0.97 per share, has a dividend yield of 4.04%. This is contrasted with the current yield of the S&P 500 and the 1.7% yield of the Oil and Gas-Refining and Marketing sector. The company’s annualized dividend growth over the previous year was 7.78%.
Pfizer Stock Dips As It Denies CEO Won EU COVID-19 Vaccine Contract Through Texting
Featured Image – Megapixl © Pcruciatti
Author Jowi Kwasu 
